Search74 Results

This policy establishes specific procedures for supplemental pay, in the form of either overload or a salary supplement, for EHRA employees. Salary supplements and overload are intended to address temporary increases in responsibility or significant and substantial duties performed under unusual circumstances outside of normal work hours.

This procedure outlines the guidelines and procedures for requesting out-of-cycle permanent increases to base salary for EHRA non-faculty employees. “Out-of-cycle” increases are any adjustments to base salary excluding adjustments accomplished as part of the normal EHRA annual raise process (ARP), a salary supplement (which is not part of base pay) or from a job change resulting from a competitive recruitment.

This document addresses UNC School of Medicine Nephropathology Laboratory general guidelines for waste management and covers laboratory safety rules and procedures for personnel, disposal boxes and sharps containers, and preparation of medical waste for contract incinerator service. This document is intended as a supplement to the McLendon Clinical Laboratories Safety Manual.

The purpose of this document is to establish a uniform policy for billing of procedures, items, or tests provided to subjects who participate in clinical research studies. This policy supplements existing policies related to the conduct of clinical research studies. This policy is applicable to medical items or services provided as part of a clinical research study; however, it does not apply to studies that do not involve human subjects.

This Policy is intended to supplement the protections afforded to UNC student-athletes by federal law, state law, and University policies. In the event of any perceived conflict between this Policy and any state or federal law, please contact a member of the Department of Athletics Executive Team.

All employers covered by OSHA’s Respirable Crystalline Silica Standards 1910.1053 and 1926.1153 must develop and implement a written exposure control plan. This plan describes tasks where employees may be exposed to silica on campus and the ways to reduce exposures through controls, work practices and housekeeping methods. This plan is a supplement to the campus policy and standard on crystalline silica.

This chapter supplements previous chapters by giving specific extra precautions, postings, training, and protective equipment necessary when working with substances that are highly toxic and/or select carcinogens. The appendices at the end of the chapter are a thorough (but not exhaustive) list of substances that might be present in your lab that are highly toxic and/or carcinogenic.

This chapter supplements previous chapters by giving specific extra precautions, postings, training, and protective equipment necessary when working with reproductive hazards. These include chemical, biological, or radiological substances that can affect the developing fetus, or the reproductive health of the male or female parents. This chapter also outlines the UNC conceptus protection policy for laboratory workers who are pregnant or contemplating pregnancy.

Workers’ Compensation benefits are available to any employee who suffers disability through accident or occupational disease arising out of, and in the course of, his or her employment, according to the provisions of the North Carolina Workers’ Compensation Act.

UNC-Chapel Hill's Office of Human Resources has on-campus, pre-approval authority for all salary actions that fall within OSHR policy guidelines and do not exceed a cumulative raise of 20% from the employee's base-salary rate on the previous June 30th, provided that we have delegated authority for the career-banded title.

This document establishes the definitions followed by the University of North Carolina at Chapel Hill (UNC-Chapel Hill) Human Research Protection Program. This is a non-exhaustive list. Regulations and other documents (e.g. guidance documents issued by federal regulatory agencies) should be referenced when applicable.

FDA regulations apply to research that involves a FDA-regulated test article in a clinical investigation involving human subjects as defined by the FDA regulations. For FDA-regulated research, the IRB must apply the FDA regulations at 21 CFR 50 and 21 CFR 56. If required by organizational policy or a FWA, 45 CFR 46 must also be applied.

All EHRA non-faculty appointments or reappointments may be made contingent on the availability of funds other than continuing state budget funds or permanent trust funds. In many instances, the contingency is related to continued sponsored research contract and grant funding. When present, this contingency permits early discontinuation of the appointment contrary to the normal appointment terms.

The purpose of this Policy is to stimulate private support and commitment to strengthening the faculties and promoting excellence the General Assembly established the Distinguished Professors Endowment Trust Fund to receive and match challenge grants to create endowed chairs for distinguished professors.

This policy defines the University's short-term investment accounts and names the types of accounts that can be invested in them. It also outlines the parameters of income distribution.